Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin

Blood

Volumn 111, Issue 10, 2008, Pages 5195-5204

  Xia, Yin ^a   Babitt, Jodie L ^a   Sidis, Yisrael ^a   Chung, Raymond T ^a   Lin, Herbert Y ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CPZN 8216   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; HEMOJUVELIN; HEPCIDIN; NEOGENIN; ACTIVIN RECEPTOR 1; ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR TYPE II A; ACTIVIN RECEPTOR TYPE II-A; ACVR1 PROTEIN, HUMAN; ANTIMICROBIAL CATIONIC PEPTIDE; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; HFE2 PROTEIN, HUMAN; LIGAND; MEMBRANE PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; CHEMISTRY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER CELL CARCINOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ACTIVIN RECEPTORS, TYPE I; ACTIVIN RECEPTORS, TYPE II; ANTIMICROBIAL CATIONIC PEPTIDES; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BONE MORPHOGENETIC PROTEINS; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; LIVER; MEMBRANE PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 46749158788     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-09-111567     Document Type: Article

References (41)

1. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117:285-297.
2. Pigeon C, Ilyin G, Courselaud B, et al. Anew mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811-7819.
3. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147-150.
4. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806-7810.
5. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferro-portin and inducing its internalization. Science. 2004;306:2090-2093.
6. Schmidtmer J, Engelkamp D. Isolation and expression pattern of three mouse homologues of chick Rgm. Gene Expr Patterns. 2004;4:105-110.
7. Samad TA, Srinivasan A, Karchewski LA, et al. DRAGON: a member of the repulsive guidance molecule-related family of neuronal- and muscle- expressed membrane proteins is regulated by DRG11 and has neuronal adhesive properties. J Neurosci. 2004;24:2027-2036.
8. Samad TA, Rebbapragada A, Bell E, et al. DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem. 2005;280:14122-14129.
9. Babbit JL, Zhang Y, Samad T, et al. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J Biol Chem. 2005;280:29820-29827.
10. Babitt JL, Huang FW, Wrighting DM, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38:531-539.
11. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGFβ family signalling. Nature. 2003;425:577-584.
12. Massague J, Chen YG. Controlling TGF-β signaling. Genes Dev. 2000;14:627-644.
13. Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell. 2003;113:685-700.
14. Shimasaki S, Moore RK, Otsuka F, Erickson G. F. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev. 2004;25:72-101.
15. Truksa J, Peng H, Lee P, Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A. 2006;103:10289-10293.
16. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest. 2007;117:1933-1939.
17. Wang RH, Li C, Xu X, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2005;2:399- 409.
18. Brown CB, Boyer AS, Runyan RB, Barnett JV. Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science. 1999;283:2080-2082.
19. Lewis KA, Gray PC, Blount AL, et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature. 2000;404:411-414.
20. Wiater E, Vale W. Inhibin is an antagonist of bone morphogenetic protein signaling. J Biol Chem. 2003;278:7934-7941.
21. del Re E, Sidis Y, Fabrizio DA, Lin HY, Schneyer A. Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system. J Biol Chem. 2004;279:53126-53135.
22. Matsunaga E, Tauszig-Delamasure S, Monnier PP, et al. RGM and its receptor neogenin regulate neuronal survival. Nat Cell Biol. 2004;6:749-755.
23. Rajagopalan S, Deitinghoff L, Davis D, et al. Neogenin mediates the action of repulsive guidance molecule. Nat Cell Biol. 2004;6:756-762.
24. Zhang AS, West AP Jr, Wyman AE, Bjorkman PJ, Enns CA. Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells. J Biol Chem. 2005;280:33885-33894.
25. Zhang AS, Anderson SA, Meyers KR, Hernandez C, Eisenstein RS, Enns CA. Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin. J Biol Chem. 2007;282:12547-12556.
26. Xia Y, Yu PB, Sidis Y, et al. Repulsive guidance molecule (RGMa) alters utilization of bone mor- phogenetic protein (BMP) type II receptors by BMP2 and BMP4. J Biol Chem. 2007;282:18129- 18140.
27. Lin L, Goldberg YP, Ganz T. Competitive regulation of hepcidin mRNA by soluble and cell- associated hemojuvelin. Blood. 2005;106:2884-2889.
28. Korchynskyi O, ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem. 2002;277:4883-4891.
29. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBOJ. 1998;17:3091-3100.
30. Truksa J, Lee P, Peng H, Flanagan J, Beutler E. The distal location of the iron responsive region of the hepcidin promoter. Blood. 2007;110:3436-3437.
31. Truksa J, Peng H, Lee P, Beutler E. Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9. Br J Haematol. 2007;139:138-147.
32. Yu PB, Beppu H, Kawai N, Li E, Bloch KD. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. J Biol Chem. 2005;280:24443-24450.
33. Mazerbourg S, Sangkuhl K, Luo CW, Sudo S, Klein C, Hsueh AJW. Identification of receptors and signaling pathways for orphan bone morpho-genetic protein/growth differentiation factor ligands based on genomic analyses. J Biol Chem. 2005;280:32122-32132.
34. Miyoshi T, Otsuka F, Suzuki J, et al. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells. Biol Reprod. 2006;74:1073-1082.
35. EbisawaT, Tada K, Kitajima I, et al. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci. 1999;112:3519-27.
36. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T. Iron-transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood. 2007;110:2182-2189.
37. Celeste AJ, Iannazzi JA, Taylor RC, et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A. 1990;87:9843-9847.
38. Glister C, Kemp CF, Knight PG. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation byfollistatin. Reproduction. 2004;127:239-254.
39. Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M, Schneyer A. Biological activityof follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology. 2006;147:3586-3597.
40. YabeT, Samuels I, Schwartz JP. Bone morphogenetic proteins BMP6 and BMP7 have differential effects on survival and neurite outgrowth of cerebellar granule cell neurons. J Neurosci Res. 2002;68:161-168.
41. Conrad S, Genth H, Hofmann F, Just I, Skutella T. Neogenin-RGMa signaling at the growth cone is bone morphogenetic protein-independent and involves RhoA, ROCK, and PKC. J Biol Chem. 2007;282:16423-16433.